BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2000
View Archived Issues
Stem cell transplant benefits some renal cell carcinoma patients
Read More
Cell growth switch enhances stem cell gene therapy
Read More
Celecoxib associated with fewer adverse effects than NSAIDs, according to CLASS
Read More
LY-339624: a new subtype-selective kainate receptor agonist
Read More
Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637
Read More
Novel RSV fusion inhibitor shows potential for prophylactic and therapeutic treatment
Read More
Inspire and Kirin enter lung diagnostic collaboration for Asia
Read More
Combination of doxazosin and amlodipine provides increased efficacy, improved tolerability
Read More
Cardioprotective agents from Pierre Fabre evaluated in several animal models
Read More
Derivatives of 4-demethylpenclomedine useful as antitumor agents
Read More
U. of Toledo describes new class of muscarinic receptor agonists
Read More
Synthesis and use of heterocyclic neurotrophic agents reported by NeuroSearch
Read More
Kirin Brewery investigates antitumor activity of quinoline and quinazoline derivatives
Read More
Vasodilating and antiplatelet series designed at Lacer
Read More
Novel 5-HT2 receptor ligands described by Vernalis for use particularly in obesity
Read More
Preparation and therapeutic use of new neurotrophic agents described in recent patent
Read More
Caspofungin, a water-soluble echinocandin antifungal, highlighted at ICAAC this week
Read More
Japanese lab identifies benzimidazole-based antitumor agents
Read More
Scotia updates development projects for first half 2000
Read More
Long-term therapy with entecavir assessed in woodchuck model of chronic HBV infection
Read More
Deltagen and Glaxo Wellcome enter genetics agreements
Read More
Aurora Biosciences announces therapeutic drug discovery alliance
Read More
Atrisorb barrier with doxycycline approved by FDA
Read More
Zonagen's product for FSD shows promise in clinical trial
Read More
Immtech International receives SBIR grant for DB-289
Read More
Complement inhibitor TP-10 to enter phase IIb studies in infants
Read More